MEDVi vs Remedy Meds vs PlexusDx: Costs & Plan Terms

Last updated: September 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies and weight-management care. Browse all Peptides & GLP-1 education

Editorial note: PlexusDx publishes this editorial review and offers one of the programs discussed. PlexusDx is not affiliated with MEDVi and has no commercial relationship with the companies named in this article; there are no affiliate links. Information is based on the sources and dates shown.

All three programs sell compounded semaglutide and tirzepatide injections, so this is a like-for-like comparison on price and terms. MEDVi's compounded semaglutide injection is $179 for a new patient's first month, then $299 per billing cycle at refill as displayed September 22, 2026; MEDVi's ongoing month-to-month rate for compounded tirzepatide injection is $399, verified September 22, 2026, with its tirzepatide first-month offer shown after the questionnaire. Remedy Meds' campaign pages show semaglutide injection at $299/mo recurring and tirzepatide injection at $399/mo recurring, with lower first-month rates on those pages. PlexusDx charges a flat $189/mo for Semaglutide Injection and $289/mo for Tirzepatide Injection month-to-month, with no first-month step-up and no membership. Terms differ as much as prices, so read both before choosing.

Three-provider shortlist

MEDVi is a telehealth platform; prescriptions are issued by licensed providers in its network and filled by compounding pharmacies it names (Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding). Remedy Meds is a telehealth program that includes the prescription, physician care, cold-chain shipping and clinician access in its monthly price, serving all 50 states plus DC. PlexusDx connects you to an independent network of U.S.-licensed clinicians through a state-licensed telehealth platform, with medication prepared by state-licensed 503A compounding pharmacies, for eligible adults in all 50 states; five states require a scheduled video consultation.

Medication and route match

Each offers compounded semaglutide injection and compounded tirzepatide injection. MEDVi adds a daily compounded semaglutide tablet and a branded Wegovy® and Zepbound® pathway priced as a monthly membership plus medication. Remedy Meds' public pages list injections; its microdose and branded pricing are not published. PlexusDx adds Semaglutide Oral, Tirzepatide Oral and a Microdose GLP-1 Protocol. Compounded semaglutide and tirzepatide are not FDA-approved drug products and are not the same as Wegovy®, Ozempic®, Zepbound® or Mounjaro®. Brand-drug trial results do not establish identical outcomes for a compounded injection. The FDA's position is summarized in its statement on unapproved GLP-1 drugs.

Monthly cost and required upfront cash

PlexusDx publishes this comparison and offers one of the programs discussed. Information is based on the sources and dates shown.

Checked September 22, 2026. MEDVi's ongoing month-to-month rates ($299 semaglutide, $399 tirzepatide) were verified September 22, 2026; confirm current pricing in its offer. Remedy Meds' figures come from campaign-parameterized product pages and its default checkout price may differ. PlexusDx figures are month-to-month rates from its product pages; 3- and 6-month commitment tiers are listed separately below.

Worked totals for semaglutide, same route. MEDVi new patient, intro plus (n − 1) refills: $777 for three cycles, $1,674 for six, $3,468 for twelve, assuming the $299 refill holds and each cycle bills once. Remedy Meds' default and multi-month totals are unknown, so no total is computed. PlexusDx Semaglutide Injection month-to-month: $567, $1,134 and $2,268. For tirzepatide, PlexusDx month-to-month is $867, $1,734 and $3,468; MEDVi refill-only at its ongoing $399 rate (verified September 22, 2026) is $1,197, $2,394 and $4,788, and no new-patient MEDVi tirzepatide total is computed because its first-month offer is not published. Like for like, that is $289/mo at PlexusDx versus MEDVi's ongoing $399/mo, $110 a month less at PlexusDx; $3,468 versus $4,788 over twelve billing cycles at the ongoing rates. MEDVi offers 3-, 6- and 12-month bundles; their rates appear in its signup flow and are not published here.

PlexusDx commitment tiers, labeled as such: Semaglutide Injection at an advertised $169/mo on a 3-month commitment (commitment total $507) or $149/mo on a 6-month commitment ($894); Tirzepatide Injection at $269/mo on 3 months ($807) or $249/mo on 6 months ($1,494). The payment schedule and any refund terms for a multi-month plan are shown at checkout. The full MEDVi price picture is in MEDVi Cost: Semaglutide, Tirzepatide, Membership, and Plan Prices.

Commitment and cancellation

MEDVi: cancel anytime with a request at least 72 hours before the next billing date, by email or portal chat; service runs to the end of the cycle; no refund for the month in which you cancel; full refund only within the first 72 hours without services or on medical disqualification; multi-month plans refundable only for months with no medication shipped; consult fees non-refundable. Its cycle length is not published, so figures here are per billing cycle.

Remedy Meds: 48-hour notice to cancel before the term ends; its membership fee is non-refundable; it advertises a 365-day money-back guarantee with strict conditions, including twelve continuous months on standard-dose compounded medication and a claim window after the thirteenth shipment. Read the guarantee terms in full before counting on it.

PlexusDx: month-to-month plans cancel anytime with no long-term contract and no cancellation fee; nothing is charged until a provider approves a prescription.

Support inclusions

MEDVi lists physician review, a personalized plan, 1:1 guidance, a metabolic report, free dietitian visits and care coaching, unlimited 24/7 support, free shipping and HSA/FSA acceptance. Remedy Meds lists the prescription, MD care, cold-chain shipping and unlimited clinician access. PlexusDx's monthly price covers the provider visit, prescription, medication and shipping, with treatment decisions made by your independent prescribing clinician. Publicly posted MEDVi customer reviews describe a range of support experiences; those are self-reported and not verified here.

Which option fits each priority?

Whichever you choose, a licensed clinician decides whether medication is appropriate. Compare current PlexusDx plans on the Weight Management Protocols collection, or read the two-way MEDVi vs PlexusDx comparison.

A note on genetics (optional)

PlexusDx offers compounded semaglutide and tirzepatide through its Weight Management Protocols. Separately, and only if it interests you, the GLP-1 & Peptide Pathways Genetic Test ($298) analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, MC4R and TCF7L2 that relate to appetite and glucose-handling pathways. It does not predict how you will respond to any medication and does not tell you which drug, dose or provider is right for you; it is context for a conversation with your clinician. Test before you invest, and treat genetics as a guide, not a guarantee.

This article is educational. PlexusDx is not affiliated with MEDVi and has no commercial relationship with the companies discussed. PlexusDx offers compounded semaglutide and tirzepatide through its own Weight Management Protocols; this article compares approaches in the GLP-1 telehealth space. The GLP-1 & Peptide Pathways Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not predict response to any specific medication and does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol. Compounded semaglutide and tirzepatide are not FDA-approved drug products; they are prepared by state-licensed compounding pharmacies under federal compounding rules and are not the same as Wegovy®, Ozempic®, Zepbound® or Mounjaro®. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company; Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. PlexusDx is not affiliated with or endorsed by either company.

Frequently Asked Questions

Is Remedy Meds cheaper than MEDVi for semaglutide?

On the figures published September 22, 2026, they match: Remedy Meds shows $299 per month recurring with a $179 first month on its campaign pages, and MEDVi shows $179 for the first month then $299 per cycle at refill. Remedy Meds' default checkout price may differ from its campaign pages, and MEDVi's refill price should be confirmed in its offer.

Which of the three publishes a tirzepatide price?

Remedy Meds publishes tirzepatide injection at $399 per month recurring, with $279 for the first month on campaign pages. PlexusDx publishes Tirzepatide Injection at $289 per month month-to-month, flat across doses. MEDVi's ongoing month-to-month rate for compounded tirzepatide injection is $399, verified September 22, 2026; MEDVi shows its tirzepatide first-month offer after the questionnaire, so confirm that figure in its official offer.

How do cancellation windows compare?

MEDVi asks for a cancellation request at least 72 hours before the next billing date and does not refund the month in which you cancel. Remedy Meds requires 48 hours' notice before the term ends and its membership fee is non-refundable. PlexusDx month-to-month plans cancel anytime with no long-term contract and no cancellation fee.

Does Remedy Meds really offer a money-back guarantee?

Remedy Meds advertises a 365-day money-back guarantee, but with strict conditions: twelve continuous months on standard-dose compounded medication and a claim filed within a set window after the thirteenth shipment. It is a long-horizon guarantee, not a trial refund. Read the full terms on Remedy Meds' site before treating it as a safety net.

Do I pay before a provider approves my prescription at each program?

PlexusDx states you pay $0 until your provider approves your prescription. MEDVi's and Remedy Meds' public pages do not state when the first charge occurs relative to clinical review, so ask each before entering payment details. MEDVi's policy allows a full refund on medical disqualification, and Remedy Meds' consult and membership fee terms are described as non-refundable.

Sources and dates checked

• MEDVi program page (glp1.medvi.org), read September 22, 2026
• MEDVi cancellation and refund policy, read September 22, 2026
• Remedy Meds official site and campaign product pages, read September 22, 2026
• PlexusDx Semaglutide Injection product page, read September 22, 2026
• PlexusDx Tirzepatide Injection product page, read September 22, 2026
• FDA: concerns with unapproved GLP-1 drugs used for weight loss

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. Sources and the dates they were checked are listed at the end of the article.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services, and offers compounded GLP-1 programs through its Weight Management Protocols. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.